The New Chemist’s Podcasting Group — The Path to KOLs: Accelerating First-in-Human in LATAM — Julio G. Martinez-Clark, CEO, bioaccess® w/ Chadwin Hanna, MD-PhD Student (UF) and David Ferguson (Host)

https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/72/f6/3a/72f63a4f-b9be-e852-5b7d-b4b3d6b1d4f5/mza_17673394441249925433.jpg/600x600bb.jpg

The Current: Discovering Chemistry's Zeitgeist

Mr. D.J. Ferguson, BS, MS, BCMAS, MRSB MRSC

323 episodes

1 day ago

To shape the future, you have to understand the current. This is The Current: Discovering Chemistry's Zeitgeist, the student-led show that plugs you directly into the momentum of modern science. We explore how research, leadership, and innovation are fueled by the spirit of our age. Join us for insights from influential minds like Dr. Robert Langer, Chancellor Gary May, Dean Raheem Beyah from Georgia Tech, Dr. Todd Golub from The Broad Institute of Harvard and MIT, and Greg Zuckerman of The Wall Street Journal, in conversations designed to inspire the next generation of scientific leaders.

Chemistry

Science

RSS

All content for The Current: Discovering Chemistry's Zeitgeist is the property of Mr. D.J. Ferguson, BS, MS, BCMAS, MRSB MRSC and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Chemistry

Science

https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_episode/7605281/7605281-1754931868444-fb5641afa64cb.jpg

The New Chemist’s Podcasting Group — The Path to KOLs: Accelerating First-in-Human in LATAM — Julio G. Martinez-Clark, CEO, bioaccess® w/ Chadwin Hanna, MD-PhD Student (UF) and David Ferguson (Host)

The Current: Discovering Chemistry's Zeitgeist

58 minutes 54 seconds

1 month ago

---

On The Path to KOLs from The New Chemist’s Podcasting Group, hosts David Ferguson and Chadwin Hanna explore how Latin America is becoming a strategic engine for high-quality, cost-effective clinical research.

Julio G. Martinez-Clark—Ambassador of IAOCR/GCSA Americas and CEO of bioaccess®—breaks down how aligning to global competence standards and smarter site activation can compress timelines for First-in-Human and Early Feasibility Studies without compromising quality. He shares lessons from pioneering trials, practical blueprints for building city-level clinical hubs, and pragmatic guidance for innovators entering LATAM markets. The conversation also touches on sustaining regional infrastructure, cross-border collaboration, and the mindset behind his long-running Global Trial Accelerators™ series.

Guest: Julio G. Martinez-Clark, CEO, bioaccess®
Hosts: David Ferguson, BS, MS, Pharm.D. Candidate; Chadwin Hanna, MD Candidate & PhD Student

Please note: The views of this podcast reflect those of my guest(s) and I, and do not constitute medical advice, consultation and suggestions. Please see a board certified and state licensed medical professional.